QC
NXTM

Quadrature Capital’s NxStage Medical Inc. NXTM Stock Holding History

Quadrature Capital’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,932
Closed -$324K – 819
2016
Q2 		$324K Buy
+14,932
New +$266K 0.02% 424

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quadrature Capital's NXTM Position: Q3 2016 in Review

Quadrature Capital sold out of NxStage Medical Inc. (NXTM) in Q3 2016, closing a stake of 14,932 shares — an estimated $324K sold.

Quadrature Capital first reported a position in NXTM in Q2 2016 and held it in 1 quarter. The position peaked at $324K in Q2 2016. 156 funds tracked by Wall St. Rank hold NXTM as of Q3 2016.

  • Quadrature Capital reported no remaining NxStage Medical Inc. position as of Q3 2016 after selling out during the quarter.
  • Quadrature Capital sold 14,932 NxStage Medical Inc. shares in Q3 2016, an estimated $324K.
  • Quadrature Capital first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 1 quarter.
  • Quadrature Capital's NxStage Medical Inc. position peaked at $324K in Q2 2016.
  • 156 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2016.

Based on Quadrature Capital's 13F filing for Q3 2016, filed 10 Nov 2016.